Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SOX9 |
| Upstream (Parents) |
|---|
| (<<) BZW2 → SOX9 |
| (<<) FUT2 → SOX9 |
| (<<) MAT2A → SOX9 |
| (<<) MYC → SOX9 |
| (<<) PABPC3 → SOX9 |
| (<<) PLCG2 → SOX9 |
| (<<) RPL35 → SOX9 |
| (<<) SET → SOX9 |
| (<<) TFPI2 → SOX9 |
| Downstream (Children) |
|---|
| SOX9 → ADORA2B (>>) |
| SOX9 → B3GNT3 (>>) |
| SOX9 → BAALC (>>) |
| SOX9 → BCL2L1 (>>) |
| SOX9 → CDK8 (>>) |
| SOX9 → CEBPA (>>) |
| SOX9 → CXCL3 (>>) |
| SOX9 → DDR1 (>>) |
| SOX9 → EFNB2 (>>) |
| SOX9 → ELF1 (>>) |
| SOX9 → ELF3 (>>) |
| SOX9 → EPHB3 (>>) |
| SOX9 → G0S2 (>>) |
| SOX9 → GDF15 (>>) |
| SOX9 → IL23A (>>) |
| SOX9 → IQSEC2 (>>) |
| SOX9 → ITGB4 (>>) |
| SOX9 → JUN (>>) |
| SOX9 → LIG1 (>>) |
| SOX9 → MAPK13 (>>) |
| SOX9 → PIK3C2B (>>) |
| SOX9 → RPIA (>>) |
| SOX9 → SF3A2 (>>) |
| SOX9 → SPRR2C (>>) |
| SOX9 → SPRY2 (>>) |
| SOX9 → TSC22D1 (>>) |
